Vanguard Group Inc. Reduces Position in Archer Daniels Midland Company $ADM

Vanguard Group Inc. trimmed its position in Archer Daniels Midland Company (NYSE:ADM) by 2.6% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 58,643,852 shares of the company’s stock after selling 1,563,943 shares during the period. Vanguard Group Inc. owned approximately 0.12% of Archer Daniels Midland worth $3,503,384,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the company. Trust Co. of Vermont increased its position in shares of Archer Daniels Midland by 367.0% in the third quarter. Trust Co. of Vermont now owns 509 shares of the company’s stock valued at $30,000 after acquiring an additional 400 shares during the period. Elevation Point Wealth Partners LLC bought a new stake in shares of Archer Daniels Midland in the second quarter worth about $36,000. Evelyn Partners Investment Management Services Ltd purchased a new position in Archer Daniels Midland during the 2nd quarter valued at about $37,000. Vermillion & White Wealth Management Group LLC raised its position in Archer Daniels Midland by 61.2% during the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 698 shares of the company’s stock valued at $37,000 after purchasing an additional 265 shares during the last quarter. Finally, Westpac Banking Corp lifted its holdings in Archer Daniels Midland by 38.0% in the 2nd quarter. Westpac Banking Corp now owns 733 shares of the company’s stock worth $39,000 after buying an additional 202 shares during the period. Hedge funds and other institutional investors own 78.28% of the company’s stock.

Archer Daniels Midland Stock Performance

Archer Daniels Midland stock opened at $67.40 on Thursday. Archer Daniels Midland Company has a twelve month low of $40.98 and a twelve month high of $70.09. The company has a quick ratio of 0.92, a current ratio of 11.20 and a debt-to-equity ratio of 0.33. The company has a market capitalization of $32.39 billion, a P/E ratio of 30.36, a PEG ratio of 0.92 and a beta of 0.71. The stock’s 50 day moving average is $63.41 and its 200 day moving average is $61.45.

Archer Daniels Midland (NYSE:ADM) last released its earnings results on Tuesday, February 3rd. The company reported $0.87 EPS for the quarter, topping analysts’ consensus estimates of $0.80 by $0.07. Archer Daniels Midland had a return on equity of 7.39% and a net margin of 1.34%.The firm had revenue of $18.56 billion for the quarter, compared to analysts’ expectations of $21.03 billion. During the same period in the prior year, the firm posted $1.14 earnings per share. The company’s quarterly revenue was down 13.7% on a year-over-year basis. Archer Daniels Midland has set its FY 2026 guidance at 3.600-4.250 EPS. On average, equities research analysts predict that Archer Daniels Midland Company will post 4.31 earnings per share for the current fiscal year.

Archer Daniels Midland Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 10th. Shareholders of record on Tuesday, February 17th will be paid a dividend of $0.52 per share. The ex-dividend date is Tuesday, February 17th. This represents a $2.08 dividend on an annualized basis and a yield of 3.1%. This is an increase from Archer Daniels Midland’s previous quarterly dividend of $0.51. Archer Daniels Midland’s dividend payout ratio (DPR) is 93.69%.

Insider Activity

In other news, Director David R. Mcatee II bought 7,500 shares of the company’s stock in a transaction dated Thursday, February 5th. The shares were purchased at an average price of $64.90 per share, for a total transaction of $486,750.00. Following the completion of the purchase, the director owned 7,500 shares in the company, valued at approximately $486,750. This represents a ∞ increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 1.20% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the company. Weiss Ratings restated a “hold (c)” rating on shares of Archer Daniels Midland in a report on Wednesday, January 21st. Morgan Stanley downgraded shares of Archer Daniels Midland from an “equal weight” rating to an “underweight” rating and reduced their price objective for the company from $57.00 to $50.00 in a research report on Tuesday, December 16th. BMO Capital Markets reaffirmed a “market perform” rating and issued a $63.00 target price on shares of Archer Daniels Midland in a research report on Wednesday, February 4th. Zacks Research upgraded shares of Archer Daniels Midland from a “strong sell” rating to a “hold” rating in a research report on Friday, January 23rd. Finally, JPMorgan Chase & Co. increased their target price on Archer Daniels Midland from $60.00 to $61.00 and gave the stock an “underweight” rating in a research report on Wednesday, February 4th. One analyst has rated the stock with a Buy rating, five have assigned a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Reduce” and an average price target of $57.00.

Archer Daniels Midland Company Profile

Archer Daniels Midland Company (ADM) is a global agricultural processor and food-ingredient provider that sources, transports and processes oilseeds, corn, wheat and other agricultural commodities. The company operates large-scale crushing, refining and processing facilities that produce vegetable oils, protein meals, corn sweeteners, starches, ethanol, animal feeds and a wide range of food and industrial ingredients. ADM also develops specialty ingredients and solutions for human and animal nutrition, food and beverage formulation, and industrial applications such as bio-based materials and renewable fuels.

ADM’s business combines commodity origination and merchandising with downstream manufacturing and ingredient formulation.